CE Mark Approval for Shift Labs’ DripAssist Infusion Rate Monitor



Three months ago we sat down with Dr. Beth Kolko, CEO of Shift Labs, to learn more about DripAssist Infusion Rate Monitor, a device that automates the calculation of IV infusion drip rates and total infusion volumes while also being able to alert a nurse when a drip rate changes or stops. At that time, DripAssist had already been FDA approved. At the end of last month, Shift Labs completed another regulatory milestone by securing CE Mark approval for DripAssist. Following this announcement, European Union member countries will now be able to benefit from accurate medication dosing as well as infusion time and cost savings that DripAssist has already been able to deliver in over 15 countries...

View Artcle Here